Child 0 5 0 5 B-clinical_variable
- 5 6 5 6 I-clinical_variable
Pugh 6 10 6 10 I-clinical_variable
score 11 16 11 16 I-clinical_variable
group 17 22 17 22 O
A 23 24 23 24 O
or 25 27 25 27 O
B7 28 30 28 30 O
liver 31 36 31 36 B-clinical_variable
functional 37 47 37 47 I-clinical_variable
score 48 53 48 53 I-clinical_variable

Confirmed 0 9 54 63 O
diagnosis 10 19 64 73 O
of 20 22 74 76 O
HCC 23 26 77 80 B-clinical_variable
> 27 28 81 82 O
10 29 31 83 85 B-lower_bound
mm 32 34 86 88 I-lower_bound
with 35 39 89 93 O
a 40 41 94 95 O
characteristic 42 56 96 110 O
4 57 58 111 112 B-treatment
- 58 59 112 113 I-treatment
phase 59 64 113 118 I-treatment
CT 65 67 119 121 I-treatment
or 68 70 122 124 O
dynamic 71 78 125 132 B-treatment
contrast 79 87 133 141 I-treatment
enhanced 88 96 142 150 I-treatment
MRI 97 100 151 154 I-treatment
finding 101 108 155 162 O
showing 109 116 163 170 O
intense 117 124 171 178 O
arterial 125 133 179 187 O
uptake 134 140 188 194 O
followed 141 149 195 203 O
by 150 152 204 206 O
washout 153 160 207 214 O
of 161 163 215 217 O
contrast 164 172 218 226 O
in 173 175 227 229 O
the 176 179 230 233 O
venous 180 186 234 240 O
- 186 187 240 241 O
delayed 187 194 241 248 O
phases 195 201 249 255 O
per 202 205 256 259 O
American 206 214 260 268 O
Association 215 226 269 280 O
for 227 230 281 284 O
the 231 234 285 288 O
Study 235 240 289 294 O
of 241 243 295 297 O
Liver 244 249 298 303 O
Disease 250 257 304 311 O
( 258 259 312 313 O
AASLD 259 264 313 318 O
) 264 265 318 319 O
criteria 266 274 320 328 O

ECOG 0 4 329 333 B-clinical_variable
score 5 10 334 339 I-clinical_variable
0 11 12 340 341 B-lower_bound
- 12 13 341 342 O
1 13 14 342 343 B-upper_bound
with 15 19 344 348 O
no 20 22 349 351 O
known 23 28 352 357 O
cardiac 29 36 358 365 B-chronic_disease
, 36 37 365 366 O
pulmonary 38 47 367 376 B-chronic_disease
or 48 50 377 379 O
renal 51 56 380 385 B-chronic_disease
dysfunction 57 68 386 397 I-chronic_disease

Liver 0 5 398 403 B-cancer
metastatic 6 16 404 414 I-cancer
gastrointestinal 17 33 415 431 I-cancer
cancer 34 40 432 438 I-cancer

No 0 2 439 441 O
TAE 3 6 442 445 B-treatment
/ 6 7 445 446 O
TACE 7 11 446 450 B-treatment
in 12 14 451 453 O
the 15 18 454 457 O
past 19 23 458 462 O

Patients 0 8 463 471 O
are 9 12 472 475 O
candidates 13 23 476 486 O
for 24 27 487 490 O
TAE 28 31 491 494 B-treatment
or 32 34 495 497 O
Transarterial 35 48 498 511 B-treatment
ChemoEmbolization 49 66 512 529 I-treatment
( 67 68 530 531 I-treatment
TACE 68 72 531 535 I-treatment
) 72 73 535 536 I-treatment
. 73 74 536 537 O
No 75 77 538 540 O
tumor 78 83 541 546 B-cancer
invasion 84 92 547 555 O
to 93 95 556 558 O
portal 96 102 559 565 O
vein 103 107 566 570 O
or 108 110 571 573 O
thrombosis 111 121 574 584 B-chronic_disease
in 122 124 585 587 I-chronic_disease
portal 125 131 588 594 I-chronic_disease
vein 132 136 595 599 I-chronic_disease

Patients 0 8 600 608 O
between 9 16 609 616 O
ages 17 21 617 621 B-age
20 22 24 622 624 B-lower_bound
and 25 28 625 628 O
80 29 31 629 631 B-upper_bound

Patients 0 8 632 640 O
have 9 13 641 645 O
normal 14 20 646 652 O
organ 21 26 653 658 O
function 27 35 659 667 O
: 35 36 667 668 O
ANC 37 40 669 672 B-clinical_variable
≥ 41 42 673 674 O
1000 43 47 675 679 B-lower_bound
/µL 48 51 680 683 I-lower_bound
, 51 52 683 684 O
Hemoglobin 53 63 685 695 B-clinical_variable
≥ 64 65 696 697 O
9 66 67 698 699 B-lower_bound
gm 68 70 700 702 I-lower_bound
/ 70 71 702 703 I-lower_bound
dL 71 73 703 705 I-lower_bound
, 73 74 705 706 O
Platelets 75 84 707 716 B-clinical_variable
≥ 85 86 717 718 O
50,000 87 93 719 725 B-lower_bound
/µL 94 97 726 729 I-lower_bound
, 97 98 729 730 O
Creatinine 99 109 731 741 B-clinical_variable
≤ 110 111 742 743 O
2 112 113 744 745 B-upper_bound
mg 114 116 746 748 I-upper_bound
/ 116 117 748 749 I-upper_bound
dL 117 119 749 751 I-upper_bound
, 119 120 751 752 O
AST 121 124 753 756 B-clinical_variable
and 125 128 757 760 O
ALT 129 132 761 764 B-clinical_variable
< 133 134 765 766 O
5 135 136 767 768 B-upper_bound
X 137 138 769 770 I-upper_bound
upper 139 144 771 776 I-upper_bound
normal 145 151 777 783 I-upper_bound
limit 152 157 784 789 I-upper_bound
of 158 160 790 792 O
the 161 164 793 796 O
current 165 172 797 804 O
institution 173 184 805 816 O
; 184 185 816 817 O
bilirubin 186 195 818 827 B-clinical_variable
≤ 196 197 828 829 O
3.0 198 201 830 833 B-upper_bound
mg 202 204 834 836 I-upper_bound
/ 204 205 836 837 I-upper_bound
dL 205 207 837 839 I-upper_bound
, 207 208 839 840 O
PT 209 211 841 843 B-clinical_variable
prolongation 212 224 844 856 I-clinical_variable
no 225 227 857 859 O
more 228 232 860 864 O
than 233 237 865 869 O
4 238 239 870 871 B-upper_bound
sec 240 243 872 875 I-upper_bound
above 244 249 876 881 I-upper_bound
upper 250 255 882 887 I-upper_bound
limit 256 261 888 893 I-upper_bound
of 262 264 894 896 I-upper_bound
normal 265 271 897 903 I-upper_bound

Patients 0 8 904 912 O
with 9 13 913 917 O
single 14 20 918 924 O
or 21 23 925 927 O
multiple 24 32 928 936 O
( 33 34 937 938 O
2 34 35 938 939 O
- 35 36 939 940 O
4 36 37 940 941 O
nodules 38 45 942 949 O
) 45 46 949 950 O
HCC 47 50 951 954 B-cancer
who 51 54 955 958 O
are 55 58 959 962 O
unsuitable 59 69 963 973 O
or 70 72 974 976 O
unwilling 73 82 977 986 O
for 83 86 987 990 O
surgical 87 95 991 999 B-treatment
resection 96 105 1000 1009 I-treatment
or 106 108 1010 1012 O
RFA 109 112 1013 1016 B-treatment
. 112 113 1016 1017 O
The 114 117 1018 1021 O
largest 118 125 1022 1029 O
tumor 126 131 1030 1035 B-cancer
nodule 132 138 1036 1042 O
should 139 145 1043 1049 O
be 146 148 1050 1052 O
less 149 153 1053 1057 O
than 154 158 1058 1062 O
10 159 161 1063 1065 B-upper_bound
cm 162 164 1066 1068 I-upper_bound
in 165 167 1069 1071 O
the 168 171 1072 1075 O
largest 172 179 1076 1083 O
diameter 180 188 1084 1092 O
. 188 189 1092 1093 O
The 190 193 1094 1097 O
total 194 199 1098 1103 O
volume 200 206 1104 1110 O
of 207 209 1111 1113 O
tumor 210 215 1114 1119 O
can 216 219 1120 1123 O
not 219 222 1123 1126 O
exceed 223 229 1127 1133 O
50 230 232 1134 1136 B-upper_bound
% 232 233 1136 1137 I-upper_bound
of 234 236 1138 1140 O
liver 237 242 1141 1146 O
; 242 243 1146 1147 O
or 244 246 1148 1150 O
patients 247 255 1151 1159 O
with 256 260 1160 1164 O
liver 261 266 1165 1170 B-cancer
metastatic 267 277 1171 1181 I-cancer
gastrointestinal 278 294 1182 1198 I-cancer
cancer 295 301 1199 1205 I-cancer
, 301 302 1205 1206 O
including 303 312 1207 1216 O
neuroendocrine 313 327 1217 1231 B-cancer
tumor 328 333 1232 1237 I-cancer

Prior 0 5 1238 1243 B-treatment
local 6 11 1244 1249 I-treatment
therapies 12 21 1250 1259 I-treatment
such 22 26 1260 1264 O
as 27 29 1265 1267 O
surgical 30 38 1268 1276 B-treatment
resection 39 48 1277 1286 I-treatment
, 48 49 1286 1287 O
radiofrequency 50 64 1288 1302 B-treatment
ablation 65 73 1303 1311 I-treatment
, 73 74 1311 1312 O
or 75 77 1313 1315 O
alcohol 78 85 1316 1323 B-treatment
injection 86 95 1324 1333 I-treatment
are 96 99 1334 1337 O
allowed 100 107 1338 1345 O
as 108 110 1346 1348 O
long 111 115 1349 1353 O
as 116 118 1354 1356 O
tumor 119 124 1357 1362 B-cancer
progresses 125 135 1363 1373 O
from 136 140 1374 1378 O
the 141 144 1379 1382 O
prior 145 150 1383 1388 B-treatment
treatment 151 160 1389 1398 I-treatment
and 161 164 1399 1402 O
the 165 168 1403 1406 O
patients 169 177 1407 1415 O
are 178 181 1416 1419 O
still 182 187 1420 1425 O
candidates 188 198 1426 1436 O
for 199 202 1437 1440 O
TAE 203 206 1441 1444 B-treatment
. 206 207 1444 1445 O
All 208 211 1446 1449 O
prior 212 217 1450 1455 B-treatment
therapy 218 225 1456 1463 I-treatment
must 226 230 1464 1468 O
be 231 233 1469 1471 O
at 234 236 1472 1474 O
least 237 242 1475 1480 O
4 243 244 1481 1482 B-lower_bound
weeks 245 250 1483 1488 I-lower_bound
prior 251 256 1489 1494 I-lower_bound
to 257 259 1495 1497 O
enrollment 260 270 1498 1508 O
and 271 274 1509 1512 O
free 275 279 1513 1517 O
from 280 284 1518 1522 O
treatment 285 294 1523 1532 O
- 294 295 1532 1533 O
related 295 302 1533 1540 O
toxicity 303 311 1541 1549 O

Unresectable 0 12 1550 1562 O
, 12 13 1562 1563 O
locally 14 21 1564 1571 B-cancer
advanced 22 30 1572 1580 I-cancer
or 31 33 1581 1583 O
metastatic 34 44 1584 1594 B-cancer
, 44 45 1594 1595 O
well 46 50 1596 1600 B-cancer
differentiated 51 65 1601 1615 I-cancer
( 66 67 1616 1617 O
low 67 70 1617 1620 O
or 71 73 1621 1623 O
intermediate 74 86 1624 1636 O
grade 87 92 1637 1642 O
) 92 93 1642 1643 O
, 93 94 1643 1644 O
neuroendocrine 95 109 1645 1659 B-cancer
tumors 110 116 1660 1666 I-cancer
( 117 118 1667 1668 I-cancer
NET 118 121 1668 1671 I-cancer
) 121 122 1671 1672 I-cancer

